| OAB0205 | Probability of AIDS and non-AIDS-related mortality of early-treated children living with HIV-1 | Oral abstract session with live Q&A | ARV management strategies in paediatric and adolescent populations |
| OAB0302 | Efficacy and safety of dolutegravir plusemtricitabinevs combined antiretroviral therapy for the maintenance of viral suppression: 144-week results of the SIMPL'HIV trial | Oral abstract session with live Q&A | ART in acute, first- and second-line therapies |
| OAB0303 | Dual therapy based on DRVr plus 3TC in HIV-1 naïve patients: global 48 week results from ANDES Study | Oral abstract session with live Q&A | ART in acute, first- and second-line therapies |
| OAB0304 | Dolutegravir versus efavirenz-400 as first-line ART in Cameroon: week 192 data of NAMSAL trial | Oral abstract session with live Q&A | ART in acute, first- and second-line therapies |
| OAB0305 | Survival in advanced AIDS patients treated with efavirenz or dolutegravir in Brazil: a multicenter, observational study | Oral abstract session with live Q&A | ART in acute, first- and second-line therapies |
| OAB0402 | Efficacy and safety results in participants co-infected with HIV from TB-PRACTECAL Clinical Trial | Oral abstract session with live Q&A | Tuberculosis: Prevention, diagnosis, treatment |
| OAB0403 | Impact of a community-wide HIV test and treat intervention on population-level tuberculosis transmission in rural Uganda | Oral abstract session with live Q&A | Tuberculosis: Prevention, diagnosis, treatment |
| OAB0404 | Are people living with HIV at higher risk of severe and fatal COVID-19? | Oral abstract session with live Q&A | Clinical manifestations and features of COVID-19 and HIV co-infection |
| OAB0405 | HIV/HBV coinfection in pregnancy and response to antiretroviral therapy | Oral abstract session with live Q&A | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| OAC0102 | Progress in scaling up HIV recent infection surveillance in 13 countries: October 1, 2019 - June 30, 2021 | Oral abstract session with live Q&A | Detecting and monitoring acute and recent HIV infections |